Visibility is a powerful tool in the medical community. When the narrative around epilepsy shifts from fear to proactive safety, patients and caregivers gain a sense of agency. Recently, PATI by NeuroVice was featured on DC News Now during their "Women’s Wednesday" segment, highlighting the journey of our founder and the clinical necessity of our oral protection device.
This feature provided a platform to discuss the reality of seizure safety and the specific gaps in symptom management that PATI was designed to fill.
For many living with epilepsy, the physical risks of a seizure are compounded by the psychological weight of the unknown. Oral trauma is a frequent and painful reality that impacts both physical health and personal dignity. Seeing these challenges addressed on a major news platform validates the experiences of millions.
The segment emphasized that safety does not have to come at the expense of normalcy. By bringing the conversation into the public eye, we continue to bridge the gap between clinical innovation and the daily lives of those we serve.
The core of PATI is trauma reduction. While medical treatments focus on the neurological cause of seizures, our device focuses on the immediate environment of the patient during an event. This clinical focus on oral protection ensures that the tongue and teeth are shielded, preventing the secondary injuries that often lead to emergency room visits and prolonged recovery times.
Our device is FDA-cleared and patented, offering a level of security that was previously unavailable in a consumer-ready format. This distinction is critical for the neurologists and epileptologists who recommend PATI as part of a comprehensive symptom management plan.
As highlighted on DC News Now, NeuroVice was born from a direct understanding of what is missing in the current seizure safety landscape. Innovation is most effective when it is informed by the lived experience of the patient. We designed PATI to be intuitive, secure, and reliable, ensuring that caregivers can feel confident in the protection they are providing to their loved ones.
The recognition from DC News Now is a milestone, but our work continues. We remain committed to expanding access to PATI and ensuring that every person at risk of oral trauma during a seizure has access to professional-grade protection.
When we prioritize safety and dignity, we allow patients to focus on their lives rather than their symptoms. We invite you to explore the science behind our device and join the conversation about a safer, more secure future for the epilepsy community.
Watch the Interview here: https://www.dcnewsnow.com/video/womens-wednesday-dr-ashlyn-sanders-feb-4-2026/11491288